Sees FY24 System-wide comparable RevPAR, on a currency neutral basis up 2.0%-2.5% vs. last year. Sees FY24 Adjusted EBITDA $3.375B-$3.405B and contract acquisition costs and capital expenditures, excluding amounts reimbursed by third parties, $200M-$250M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLT: